| Report Date | |
| Manager | |
| Fund Name | |
| Strategy | |
| Latest Return Date | |
| Latest Return | |
| Latest 6 Months | |
| Latest 12 Months | |
| Latest 24 Months | |
| Annualised Since Inception | |
| Inception Date | |
| FUM (millions) | |
| Fund Overview | Whilst the Fund's primary strategy is focused on long/short equities, the ability to retain discretionary powers to allocate across a number of other investment strategies is reserved. These strategies may include, but not be limited to: convertible bond investments, portfolio hedging, equity related arbitrage, special situations (e.g. merger arbitrage, rights offerings, participation in international public offerings and placements, etc.). The Fund's geographic focus is Asia excluding Japan, but including Australia). The Fund may invest outside of this region to the extent that: 1. The investment decision is driven from the Asian region or; 2. The exposure is intended to mitigate risk or enhance return from factors external to the Asian region. |
| Manager Comments | December result was driven largely by the long positions in XREF Ltd (XF1.AX) 0.21%, Actinogen Medical Ltd (ACW.AX) 0.20% and Boral Ltd (BLD.AX) 0.14%. Detractors for the month included short positions in Cover-More Group Ltd (CVO.AX) -0.18%, Metcash Ltd (MTS.AX) -0.18% and AGL Energy Ltd (AGL.AX) -0.16%. |
| More Information |
